Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Kuopio University Hospital
The study will include 30 relapse-remitting multiple sclerosis patients. Assessments of heart rate variability and myocardial ventricular repolarisation pattern will be done 1) before fingolimod, 2) first day of fingolimod 3) after 3 months use and 4) after 12 months use of fingolimod.
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Age 18 - 65 years
Understands the proposed research and actions to be taken
The written informed consent has given
clinical indication to fingolimod-treatment
You may not be if
Patient refuses
Patient takes or has taken part in other clinical drug trial during the last month
